1. Gupta N et al. Birt-Hogg-Dube Syndrome. Clin Chest Med. 2016; 37: 475-86
2. Menko FH et al. Birt-Hogg-Dubé syndrome: diagnosis and management. Lancet Oncol. 2009; 10: 1199-206
3. Schmidt LS, Linehan WM. Molecular genetics and clinical features of Birt–Hogg–Dubé syndrome. Nat Rev Urol. 2015; 12: 558–569.
4. European BHD Consortium. www.europeanbhdconsortium.org .
5. Hornstein OP, Knickenberg M. Perifollicular fibromatosis cutis with polyps of the colon-a cutaneo-intestinal syndrome sui generis. Arch Dermatol Res. 1975; 253: 161-175.
6. Birt AR, Hogg GR, Dube WJ. Hereditary multiple fibrofolliculomas with trichodiscomas and acrochordons. Arch Dermatol.1977; 113: 1674–7.
7. Furuya M, Nakatani Y. Pathology of Birt-Hogg-Dube syndrome: A special reference of pulmonary manifestations in Japanese population with comprehensive analysis and review. Pathol Int. 2019; 69: 1-12
8. Furuya M et al. Genetic, epidemiologic and clinicopathologic studies of Japanese Asian patients with Birt-Hogg-Dubé syndrome. Clin Genet. 2016; 90: 403-412
9. Houweling A et al. Renal cancer and pneumothorax risk in Birt–Hogg–Dubé syndrome; an analysis of 115 FLCN mutation carriers from 35 BHD families. Br J Cancer. 2011; 105: 1912–1919.
10. Iwabuchi C et al. Skin lesions of Birt-Hogg-Dubé syndrome: Clinical and histopathological findings in 31 Japanese patients who presented with pneumothorax and/or multiple lung cysts. J Dermatol Sci. 2018; 89: 77-84.
11. Johannesma PC et al. Renal imaging in 199 Dutch patients with Birt–Hogg–Dubé syndrome: screening compliance and outcome. PLoS One. 2019; 14: e0212952.
12. Kluger N et al. Birt–Hogg–Dubé syndrome: clinical and genetic studies of 10 French families. Br J Dermatol. 2010; 162: 527–537.
13. Sattler EC, Steinlein OK. Birt-Hogg-Dubé Syndrome. 2020 w Adam MP, Ardinger HH, Pagon RA, i wsp. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2022. https://www.ncbi.nlm.nih.gov/books/NBK1522/
14. Lee JH et al. Birt–Hogg–Dubé syndrome in Korean: clinicoradiologic features and long-term follow-up. Korean J Intern Med. 2019; 34: 830–840
15. Liu Y et al. Clinical and genetic characteristics of Chinese patients with Birt-Hogg-Dube syndrome. Orphanet J Rare Dis. 2017; 12: 104
16. Daccord C et al. Lung function in Birt–Hogg–Dubé syndrome: a retrospective analysis of 96 patients. Orphanet J Rare Dis. 2020; 15: 120.
17. Toro JR et al. BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dubé syndrome: a new series of 50 families and a review of published reports. J Med Genet. 2008; 45: 321-331.
18. Radzikowska E et al. Familial pneumothoraces: Birt-Hogg-Dube syndrome. Pol Arch Int Med. 2016; 126: 897-898.
19. Opoka L et al. Familial pneumothoraxes – Birt-Hogg-Dubé syndrome. Differentiation with other cystic lung diseases. Pol J Radiol. 2019; 84: e424-e429
20. Radzikowska E et al. Novel folliculin gene mutations in Polish patients with Birt-Hogg-Dubé syndrome. Orphanet J Rare Dis. 2021; 16:302.
21. Gupta N et al. Spontaneous pneumothoraces in patients with Birt–Hogg–Dubé syndrome. Ann Am Thorac Soc. 2017; 14: 706–713
22. Benhammou JN et al. Identification of intragenic deletions and duplication in the FLCN gene in Birt–Hogg–Dubé syndrome. Genes Chromosomes Cancer. 2011; 50: 466–477.
23. Khoo SK et al. Birt–Hogg–Dubé syndrome: mapping of a novel hereditary neoplasia gene to chromosome 17p12-q11.2. Oncogene. 2001; 20: 5239–5242.
24. Gunji Y et al. Mutations of the Birt Hogg Dube gene in patients with multiple lung cysts and recurrent pneumothorax. J Med Genet. 2007; 44: 588–93.
25. Goncharova EA et al. Folliculin controls lung alveolar enlargement and epithelial cell survival through E-cadherin, LKB1, and AMPK. Cell Rep. 2014; 7: 412–423.
26. Kennedy JC et al. New developments in the pathogenesis of pulmonary cysts in Birt-Hogg-Dube syndrome. Semin Respir Crit Care Med. 2020; 41 :247-255
27. Lim DH et al. A new locus-specific database (LSDB) for mutations in the folliculin (FLCN) gene. Hum Mutat. 2010; 31: E1043–E1051.
28. Nahorski MS et al. Birt–Hogg–Dubé syndrome-associated FLCN mutations disrupt protein stability. Hum Mutat. 2011; 32: 921–929.
29. Nickerson ML et al. Mutations in a novel gene lead to kidney tumours, lung wall defects, and benign tumours of the hair follicle in patients with the Birt–Hogg–Dubé syndrome. Cancer Cell. 2002; 2: 157–164.
30. Painter JN et al. A 4-bp deletion in the Birt-Hogg-Dubé gene (FLCN) causes dominantly inherited spontaneous pneumothorax. Am J Hum Genet. 2005; 76: 522-527.
31. Khoo SK et al. Clinical and genetic studies of Birt-Hogg-Dubé syndrome. J Med Genet. 2002; 39: 906-912
32. Gupta N et al. Pulmonary manifestations of Birt-Hogg-Dube syndrome. Fam Cancer. 2013; 12: 387–396
33. Toro JR et al. Lung cysts, spontaneous pneumothorax, and genetic associations in 89 families with Birt-Hogg-Dube syndrome. Am J Respir Crit Care Med. 2007;175: 1044–53
34. Kunogi M et al. Clinical and genetic spectrum of Birt-Hogg-Dube syndrome patients in whom pneumothorax and/or multiple lung cysts are the presenting feature. J Med Genet. 2010;47: 281–7.
35. Furuyama M. Nakatani Y. Birt-Hogg-Dube syndrome: clinicopathological features of the lung. J Clin Pathol. 2013; 66: 178-86
36. Ebana H et al. Novel clinical scoring system to identify patients with pneumothorax with suspicion for Birt–Hogg–Dubé syndrome. Respirology. 2018; 23: 414–418
37. Benusiglio PR et al. Renal cell tumour characteristics in patients with the Birt–Hogg–Dubé cancer susceptibility syndrome: a retrospective, multicentre study. Orphanet J Rare Dis. 2014; 9: 163.
38. van de Beek I et al. No evidence for increased prevalence of colorectal carcinoma in 399 Dutch patients with Birt-Hogg-Dubé syndrome. Brit J Cancer. 2020; 122: 590–594.
39. Johannesma PC et al. Risk of spontaneous pneumothorax due to air travel and diving in patients with Birt-Hogg-Dubé syndrome. Springerplus. 2016; 5: 1506.
40. Zbar B et al. Risk of renal and colonic neoplasms and spontaneous pneumothorax in the Birt-Hogg-Dube´ syndrome. Cancer Epid Biomarkers Prev. 2002; 11: 393–400
FLCN